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 In the healthcare industry in the United States, utilization of telemedicine to treat chronic and acute care 
conditions shows promise in increasing access, decreasing costs, and improving patient satisfaction.  While 
telemedicine is not a new idea, only in recent years has there been the culmination of innovation, legislation, 
and advancement in practice to forge new virtual paths to high-quality treatment of patients through 
telemedicine utilization. The study design is a retrospective quasi-experimental cohort analysis of secondary 
patient claims data from 2012 to 2014. Using data from the Medicare Limited Data Set 5% Medicare sample, 
we compare healthcare costs for two groups of Medicare beneficiaries with chronic disease: those who utilized 
a telemedicine service and those who had a traditional face-to-face visit. Propensity score (PS) weighting was 
used to match the groups on age, race, sex, dual eligibility for Medicare and Medicaid. Analysis of the cost 
outcome utilized a gamma distributed models with log link functions controlling for age, Charlson Score, and 
Hypertension.  When examining a six-month post visit period, results found a cost saving of $1,828 for the 
Telehealth group compared to the matched group of beneficiaries with an in-person visit. Telehealth is a 
promising approach to increase access to care and is associated with decreased costs for Medicare beneficiaries 




Background and Need 
For many Americans, healthcare costs are a significant barrier to accessing quality healthcare services. 
In addition, geographic location can create a physical barrier to accessing quality healthcare providers (“Access 
to Health Services | Healthy People 2020,” n.d.). Since 1910, the medical community has been concerned with 
the preventable differences across populations in health outcomes and disease prevalence, otherwise known as 
health disparities. Often these health disparities can be attributed to social, economic, environmental, or 
geographic factors (CDC, 2015). Disparities in access to healthcare have been an issue in underserved urban 
and rural areas of the US. Disparities in health are preventable factors impacting equitable opportunities for 
health driven by socioeconomic differences (Centers for Disease Control and Prevention [CDC], 2015). In 
1910, Abraham Flexner published a study of medical education that revolutionized the training of medical 
students. The Flexner Report initiated the design of a model for medical training in an urban, university-
centered setting to allow for more specialized, concentrated education. Unfortunately, this move created a larger 
gap in access to care for those in rural settings. In 1966, the American Medical Association (AMA) reviewed 
the impact of the Flexner Report in the Millis Report and found rural areas in the country were experiencing 
growing physician shortages and worsening quality care delivery. The Millis Report was instrumental in 
highlighting the need for primary care physicians but failed to identify the need for geographical distribution of 
these providers in rural areas of the nation. Many physician training models specific to rural, comprehensive 
care delivery have been created since the Millis Report. Despite these efforts, access to quality medical care is 
still a daunting issue in underserved urban and rural healthcare areas (Rodgers, Wendling, Saba, Mahoney, & 
Speights, 2017). 
Telehealth has the potential to alleviate the barriers to care caused by the geographic misallocation of 
qualified healthcare providers. Telehealth services connect patients in rural or remote locations with distant 
providers via technology. A simple definition of telehealth is the utilization of telecommunications to facilitate 
health care delivery (Thomas, L & Capistrant, G 2017). In a traditional telehealth interaction, the distant site, 




the utilization of telecommunication technologies. An originating site or spoke is the location of the patient at 
the time a service is being provided utilizing telecommunication technologies (Medicaid.gov [Medicaid], n.d.). 
Table 1 identifies a variety of ways telecommunications are used to provide medical services via telehealth. 
One example of how telehealth can positively impact healthcare is through the Helmsley Charitable 
Trust. The Rural Health Program, initiated by the Helmsley Trust, has approved $22 million in funding for 
telehealth eEmergency Services for 85 counties in the Midwestern U.S. (Stingley & Schultz, 2014). The 
Helmsley Charitable Trust wanted to focus on providing funding for areas where immediate and sizable 
healthcare needs were present and where there was an absence of philanthropic funding. The Helmsley Trust 
focused on connecting rural hospitals in these areas with service/hub hospitals outside of the frontier areas. 
Services provided through this eEmergency initiative increased access to quality care, with faster transfers to 
higher level care facilities when needed, while also decreasing the number of unnecessary transfers. 
Additionally, telemedicine was able to provide trauma care that was absent from these areas without this 
program (Stingley & Schultz, 2014). In addition to costs and access, multiple articles reviewed reported that 
telehealth utilization resulted in increased patient engagement, empowerment, and improved mortality  (Center 
of Connected Health Policy, 2014).  
Problem Statement 
Access to affordable quality medical care is challenged by geography, socioeconomic status, availability 
of qualified medical practitioners, and other factors. Telemedicine technologies show promise in increasing 
access to care, improving outcomes, and decreasing costs for chronic disease management, but more evidence is 
needed. More extensive, large sample research is needed to determine the impact of telehealth as a modality of 
treatment on costs and outcomes of care.   
Research Question and Research Hypotheses  
This study will address two primary research questions: 1) What are the demographic characteristics of 




use of telemedicine services and any of the following healthcare outcomes: healthcare costs, outpatient costs, 
inpatient costs, or the number of inpatient admissions for Medicare beneficiaries with chronic disease?  
• Hypothesis 1: Overall healthcare costs will be less for chronic disease Medicare beneficiaries who 
utilize telemedicine services compared with Medicare beneficiaries receiving care in a traditional, face-
to-face setting. 
• Null 1: There is no difference in overall care costs between chronic disease Medicare beneficiaries who 
use telemedicine and Medicare beneficiaries receiving care in a traditional, face-to-face setting. 
• Hypothesis 2: Outpatient healthcare costs will be less for chronic disease Medicare beneficiaries who 
utilize telemedicine services compared with Medicare beneficiaries receiving care in a traditional, face-
to-face setting. 
• Null 2: There is no difference in inpatient care costs between chronic disease Medicare beneficiaries 
who use telemedicine and Medicare beneficiaries receiving care in a traditional, face-to-face setting. 
• Hypothesis 3: Inpatient healthcare costs will be less for chronic disease Medicare beneficiaries who 
utilize telemedicine services compared with Medicare beneficiaries receiving care in a traditional, face-
to-face setting. 
• Null 3: There is no difference in inpatient care costs between chronic disease Medicare beneficiaries 
who use telemedicine and Medicare beneficiaries receiving care in a traditional, face-to-face setting. 
• Hypothesis 4: Inpatient admission rates will be lower for chronic disease Medicare beneficiaries who 
utilize telemedicine services compared with Medicare beneficiaries receiving care in a traditional, face-
to-face setting. 
• Null 4: There is no difference in the rate of inpatient admissions between chronic disease Medicare 









The study includes the Limited Data Set of MEDPAR’s 5% sample for Medicare patients who were seen 
between October 1, 2012 and September 30, 2014. Data were reviewed for beneficiaries with chronic diseases 
reported on claims data with and without a modifier GT representing the presence or absence of telemedicine. 
Assumptions 
Assumptions are as follows:  Medicare claims data can be effectively matched for beneficiaries for 
inpatient and outpatient services, the presence of the GT modifier to express the use of telemedicine allowing 
appropriate grouping of visit types and costs associated with those visit types, and the correct assignment of 
diagnosis codes for accurate inclusion or exclusion based on the Elixhauser index. 
Chapter 2 Literature Review 
This literature review examines barriers to accessing quality medical care across the United States, as 
well as the empirical evidence on the impact of telemedicine on healthcare costs, quality, or access for patients 
with chronic disease. Search terms used in the review of literature include telemedicine, telehealth, costs, 
access, quality of care, chronic disease(s), chronic conditions, underserved, and rural health, all written in the 
English language. Searches were performed in Pubmed, the American Telemedicine Association, South 
Carolina Telehealth Alliance, Ameicanhealthrankings.org, and the following government websites: 
Healthypeople.gov, CDC.gov, Medicaid.gov, and AHRQ.gov.  
Barriers to Patient Access to Care  
Lack of access to quality healthcare is far reaching and has major implications for chronic disease 
management. Type 2 Diabetes Mellitus (DM2) is often associated with socioeconomic status and geography. 
Compared to the national average, the Southern United States has a higher prevalence of DM2. Residing in a 
rural area and being either white or African-American increased the incidence of DM2. The percentages of 
patients diagnosed with DM2 in rural areas in the South who had forgone medical care ranged from 13% to 
17% between 2011 and 2015 (Towne et al., 2017).  Chronic respiratory conditions are another example of 




and rural populations using data from 2010 US Census data, the National Provider Identifier Registry, and 
county-specific data from 2013 based on the Behavioral Risk Factor Surveillance System (BRFSS). Of the 45.6 
million rural residents based on 2010 census data, only 10.4% had access to a pulmonologist within 5 miles, 
34.5% within 10 miles, and 54.5% within 15 miles. The researchers reported that 95.2% or rural residents had 
access to a pulmonologist within 50 miles (Croft, Lu, Zhang, & Holt,2016).  
Another example of limited access to care are the Midwestern frontier counties of the United States. A 
frontier county is defined as a county with fewer than seven residents per square mile. The terrain in these 
counties are often agricultural and are generally secondary roads that are not well-maintained or highly traveled. 
Many of these roads are impassable during the winter months and are undergoing construction during the 
warmer months. Mobile phone service is inconsistent in many of these areas, and the majority of the population 
are elderly residents. The upper Midwest has the highest population of residents age 85 years and older. This 
aging population is susceptible to chronic disease and cancer. This population generally has an increased need 
for many types of healthcare services including elder care. In addition to these factors, there is a shortage of 
physicians in these counties, especially compared to more urban areas of the country. For example, the upper 
Midwest state of Wyoming had only 90 primary care providers per 100,000 residents, whereas New England’s 
Massachusetts had 196 primary care providers for the same number of residents. In 2013, the national average 
of physicians per 100,000 people was 121. Many rural areas fall well short of that number.  For example, in 11 
counties covering 23,787 square miles in Montana,  over 16,000 residents where there was no primary care 
provider (Stingley & Schultz, 2014).  
Access to Healthcare via Telemedicine  
According to the 2015 America’s Health Rankings, Mississippi ranked in the bottom five overall in 
healthy living and in clinical outcomes in the United States (see Figure 1). Clinical outcomes measured for these 
statistics included deaths due to cancer, cardiovascular disease, and diabetes, and clinical demographics 
included measures of health status disparity, infant mortality, premature death, and poor mental and physical 




ranking Mississippi 49th nationally (Explore Poor Mental Health Days in Mississippi, 2015 Annual Report, 
n.d.).  The social determinants of health within the state, which include where people are born, work, and live, 
are other contributing factors to the poor health outcomes and lack of access. Mississippi is largely rural, with 
the lowest physician to patient ratio in the U.S., and a high population of African Americans with more than 1/3 
of them living in poverty.  Moreover, about 165,000 Mississippi residents are uninsured. Many programs have 
failed to alleviate the health disparities in the state, including Federally Qualified Health Centers (FQHC) with 
multiple sites across the state, educational programs, Rural Health Clinics (RHC), and staffing Critical Access 
Hospitals (CAH) with nurse practitioners. FQHCs, RHCs, and CAHs were created to provide cost-based 
payments to providers, including hospitals, physicians, physician assistants, and nurse practitioners in rural or 
underserved areas (Comparison of the Rural Health Clinic and Federally Qualified Health Center Programs, 
2006).  Developed by Dr. Robert M. Galli, the TelEmergency program in Mississippi that began in 2013 was 
highly successful at using existing innovation to train clinicians and impact legislation to grow the use of 
telemedicine and expand services to include more offerings. This pilot program was for a three hospital system 
leveraging off the shelf, ready to use electronics in intensive specialized training for nurse practitioners. 
Together, the providers in this system lobbied for needed legislation and created a unique offering of medical 
services; the first of its kind in the US, it was considered to be highly successful. The telemedicine initiative in 
Mississippi has grown from being limited to offering emergency and trauma services to a wide range of services 
including telestroke, intensive care, general hospital medicine, critical care, training and development of clinical 
staff, cardiology services, and real-time consultations. This initiative has greatly increased access to medical 
services for identified health disparities in the state. In fact, only 16 of the 82 counties in the state are left 
without access to telehealth services through this CAH initiative (deShazo & Parker, 2017).  
Telemedicine as a modality of treatment shows promise in increasing access to healthcare for patients 
with chronic disease. A promising exploratory study of patients with heart failure (HF) or chronic lung disease 
(CLD) was conducted (Martín-Lesende et al., 2017). Patients with at least two admissions for HR or CLD in the 




primary care telemedicine usage for treatment of HF and CLD. Using smart phones and a specified web-based 
platform, self-reporting of prescribed clinical data was uploaded daily. The primary dependent variable was the 
number of hospital admissions in the prior year and in the year telemedicine was utilized to manage HF or CLD. 
Findings were significant for the decrease of hospital admissions for these specific conditions from 1.9 to .06 (p 
value < 0.001), all-hospital admissions from 2.6 to 1.1 (p value < 0.001), and emergency department visits from 
4.2 to 2.11 (p value < 0.001). Other reviewed findings were not significant (Martín-Lesende et al., 2017). One 
limitation of this study is that no control group was used and therefore it is difficult to determine. While results 
seem promising, further evidence-based studies of telehealth programs are needed. 
Access to care for correctional facility residents can also be improved by the use of telemedicine (Young 
& Badowski, 2017). Provision of care is expensive and time-consuming for physicians who must travel to 
correctional facilities. Patients in a correctional setting often have increased wait times to receive health care 
services. The delay in care can lead to exacerbations of conditions and increase the need for the patient to be 
taken to a facility for acute or emergency care. Outside of increased medical costs due to the need for 
emergency services, additional guards and staff must be paid to manage and transport that patient to the 
emergency facility. Telemedicine has successfully been used in correctional facilities for psychiatric, surgical, 
emergency, and multi-disciplinary needs. In a study of two adolescent housing facilities, the implementation of 
telemedicine services led to a 57% decrease in wait time and an increase of 40% in utilization of outpatient 
visits. In addition, there was a decrease in emergency visits over the course of two years (Young & Badowski, 
2017).  
Improvements in Healthcare Outcome via Telemedicine Programs 
The 2015 annual report from the South Carolina Telehealth Alliance gives a detailed look at 
accessibility of quality care being provided to its patient population via telehealth. Highlighting advances in 
many areas including, TeleStroke, TelePsych, and other areas of service, this report supports the need for 
increased access that can be provided by telemedicine. From 2008-2015 a partnership with the Medical 




consultations for TeleStroke from a very small number to about 2500. It is important to note, that after 
expansion of the Telestroke program, 96% of South Carolina residents are now within one hour of potentially 
life-saving and cost-saving, quality medical stroke care (“South Carolina Telehealth Alliance: 2015 Annual 
Report,” n.d.). 
Cost Savings via Telemedicine  
The University of California Davis Health System (UCDHS) began offering outpatient specialty 
consultations via telemedicine as early as 1996. The impact of telemedicine consultations on travel and 
environmental related savings has shown favorable results. The study, which reviewed visits between July, 
1996 and December, 2013, compared mileage between the patient’s home, the telemedicine clinic where the 
patient received care, and the face-to-face clinic at UCDHS. This study reviewed more than 11,000 unique 
patients and over 19,000 consultations. Results showed more than 5.3 million miles, just under 9 years of travel 
time, and more than $2.8 million in direct travel costs were saved over this time. The number of consultations in 
this study excluded the more than 16,000 consultations provided to inmates at correctional facilities (Navjit W. 
Dullet et al., 2017).  
In January, 2015, a study provided by the Telemedicine Services of the Veterans Health Administration 
completed a retrospective review of a group of veteran patients utilizing care coordination home telemedicine 
(CCHT) for chronic disease management (CDM) compared to a matched control group (MCG) of similar 
patients from 2009 to 2012. The outcomes of the study showed decreased costs for patients in the CCHT group. 
After 12 months of study, CCHT patients had much lower healthcare costs than the MCG matched group. 
CCHT patients had a slight decrease of 4% in costs while MCG patient costs increased by 48% (p<.001). It was 
noted pharmacy costs rose for CCHT patients by 22% compared to a smaller rise of 15% for MCG patients. 
This rise was attributed to the increased compliance with medical treatment. Other significant findings in the 
study of telemedicine in chronic disease patients included an increase in the mean number of inpatient 




days. While emergency visits decreased from .65 to .63 in MCG patients, there was a marked decrease from .84 
to .58 in CCHT patients (Darkins, Kendall, Edmonson, Young, & Stressel, 2014). 
According to the 2015 SCTA Annual Report, TeleStroke services increased the administration of tissue 
plasminogen activator (tPA) by 55% from 2014 to 2015 which resulted in a potential cost savings of $642,244. 
tPA is a blood thinner used in early treatment of strokes and blood clots. In a partnership with Tidelands Health 
and MUSC in that same time period, the number of TeleStroke consultations grew from less than 25 per year to 
just under 200 per year for Tidelands Waccamaw and from less than 25 to just under 150 for Tidelands 
Georgetown. As a result of this partnership, the number of patients transferred from Tidelands Waccamaw to 
MUSC decreased from 40 at the onset of the program to less than 20 in 2015. The number of transfers peaked in 
2009 at around 70 transfers. (“South Carolina Telehealth Alliance: 2015 Annual Report,” n.d.). This partnership 
was particularly important due to rural setting of each of these Tidelands Health facilities. Rural hospitals rely 
largely on government payments due to their small size and their low financial reserves and limited assets. 
A note-worthy study from the University of Texas Medical Branch (UTMB) touts multiple, observable 
benefits from their telemedicine services that was partially inspired by a Medicaid mandate to provide quality 
care for enrolled children (Vo, Brooks, Farr, n.d.). In response to the pediatric psychiatric providers available to 
this population of patients, UTMB partnered with community entities in 20 clinical sites throughout Texas. Per 
UTMB, their partners constantly validate the need for these services to continue based on the need for crucial 
care due to the lack of healthcare providers in those areas. These needs would not be met if the program did not 
exist. UTMB reports the national average of Medicaid children who do not show up for appointments are as 
high as 42%. The Texas program has 10% less no-shows than the national average. Additionally, there was 
more than a 50% reduction in emergency room visits of this population for psychiatric needs. Based on annual 
data from the year before this program as compared to the same data the year after the program’s 
implementation, that cost savings ranges from $11,514 to $90,512. That range is based solely on Emergency 
Room Level I, II, III, IV, or V alone and does not include other services, medications, or supplies provided 




UTMB surveyed 530 parents of this patient population and found that over 88% made access to a specialist 
easier for their families and over 60% improved overall functioning for their children in terms of psychiatric 
conditions (Vo, Brooks, Farr, n.d.).  
Conclusions 
 While the use of telemedicine in the United States is on the rise, limited research has been performed to 
prove that the cost of the programs is worth the value received by the patients, providers, insurers, and health 
systems. In particular, few national studies have examined telemedicine outcomes with emphasis on chronic 
disease patients. For these reasons, this study aims to examine the demographic characteristics of current users 
of telemedicine services who are chronic disease suffers. We will also compare a propensity score weighted 
group of chronic disease patients who have indication of use of telemedicine services with those that do not, on 
primary cost and inpatient utilization outcomes. 
Chapter 3 Methodology 
Research Design 
This study design is a retrospective quasi-experimental cohort analysis of a secondary patient claims data from 
2012 to 2014. 
Research Question and Research Hypotheses  
This study will address two primary research questions. 1) What are the demographic characteristics of 
chronic disease Medicare beneficiaries who utilize telemedicine services? 2) Is there a relationship between the 
use of telemedicine services and any of the following healthcare outcomes: healthcare costs or the number of 
inpatient admissions for Medicare beneficiaries with chronic disease?  
• Hypothesis 1: Healthcare costs will be less for chronic disease Medicare beneficiaries who utilize 
telemedicine services compared with Medicare beneficiaries receiving care in a traditional, face-to-face 
setting. 
• Null 1: There is no difference in overall care costs between chronic disease Medicare beneficiaries who 




• Hypothesis 2: Outpatient healthcare costs will be less for chronic disease Medicare beneficiaries who 
utilize telemedicine services compared with Medicare beneficiaries receiving care in a traditional, face-
to-face setting. 
• Null 2: There is no difference in inpatient care costs between chronic disease Medicare beneficiaries 
who use telemedicine and Medicare beneficiaries receiving care in a traditional, face-to-face setting. 
• Hypothesis 3: Inpatient healthcare costs will be less for chronic disease Medicare beneficiaries who 
utilize telemedicine services compared with Medicare beneficiaries receiving care in a traditional, face-
to-face setting. 
• Null 3: There is no difference in inpatient care costs between chronic disease Medicare beneficiaries 
who use telemedicine and Medicare beneficiaries receiving care in a traditional, face-to-face setting. 
• Hypothesis 4: Inpatient admission rates will be lower for chronic disease Medicare beneficiaries who 
utilize telemedicine services compared with Medicare beneficiaries receiving care in a traditional, face-
to-face setting. 
Null 4: There is no difference in the rate of inpatient admissions between chronic disease Medicare 
beneficiaries who use telemedicine and Medicare beneficiaries receiving care in a traditional, face-to-
face setting. 
Data Set Description 
 
Medicare Limited Data Set (LDS) files were the data source obtained for the comparison of the control 
and study group by reviewing claims information. The LDS file is a sample of claims data containing 
identifiable health information. The data set does not contain identifiers protected by the Health Insurance 
Accountability and Portability Act (HIPAA) (Medicare, Baltimore, & Usa, 2018). Researchers can gain access 
to this from CMS through the executions of a data use agreement. Data for this study were provided by the 
Medical University of South Carolina (MUSC) and included claims data from the 5% LDS from October 1, 






 We examined the LDS Medicare 5% sample from October 1, 2012 through September 30, 2014 for 
reporting of chronic disease. Chronic diseases were defined by examining the Elixhauser Comorbidity Index 
(ECI) for the most prevalent chronic diseases in adults. A list of diagnoses included in the ECI can be found in 
Table 2.  The ECI is a medically accepted list of comorbidities that can predict an increase in the utilization of 
healthcare resources of hospital inpatient services.  
We defined utilization of a telemedicine visit as claims reported with the GT modifier on a procedure. 
The index date for the study group was defined as the first appearance of modifier GT in claims data. For the 
control group, a similar diagnostic event was selected. Propensity score (PS) weighting was used to match the 
groups on age, race, sex, dual eligibility for Medicare and Medicaid. In addition, the presence of depression, 
DM, and/or opioid use disorder was used as additional variables. The use of propensity score weighting allows 
weights to be applied to balance baseline characteristics of the comparison groups to control for selection bias. 
Both the study and control group were followed for 6 months.  
After codifying the diseases listed on the ECI, the Medicare 5% LDS was queried and yielded four 
prevalent categories of chronic disease for inclusion on the study group: CHF, COPD, HTN, and PVD.  More 
than 2,000 individuals were identified, and they could be followed with at least one of the defined chronic 
diseases and at least one modifier code GT for the same time period. Standardized differences in means and 
proportions was used to examine the quality of the propensity score model. Covariates in the PS model that 
have a less than 0.20 standardized difference were considered well-matched. The PS were computed using a 
multiple logistic regression with comparison group (Telemedicine vs. No Telemedicine) as the dependent 
variable. PS and outcome models were utilized to account for demographics and clinical characteristics that 
may have influenced comparison group selection or may have been related to outcome risk. All  these 
designated covariates were included in the PS model and were tested for inclusion in the outcome analyses 
models to account for a doubly robust analysis methodology for quasi-experimental studies (Harder, Stuart, & 




weighted by using inverse probability of the treatment weighting (IPTW) approaches to create stabilized 
weights (Cole & Hernán, 2008; Curtis, Hammill, Eisenstein, Kramer, & Anstrom, 2007; Harder et al., 2010; 
Robins, Hernán, & Brumback, n.d.; Xu et al., 2010). The stabilized weight was the marginal probability of 
being in the tele-medicine group given no covariates, divided by the propensity score (the probability of being 
in the tele-medicine group given all covariates). To assess Aim 1, describing the population of telemedicine 
users, chi-square (for categorical variables) and t-tests (for normally-distributed continuous variables) were used 
to describe the differences in demographic characteristics across the patient groups who utilized telemedicine 
services versus those who did not.  
 After the propensity score weights were developed, a series of multivariable models were constructed to 
make formal statistical comparisons testing the hypothesized differences between the telemedicine and no 
telemedicine groups.  Generalized linear regression models were used to make these comparisons. Cost 
outcomes utilized Gamma distributed models with log link functions due to the skewed nature of costs. Due to 
the count nature of the number of inpatient visits, a Negative Binomial distributed model with a log link 
function was used to test differences in this outcome. The same covariates used in the PS model were tested for 
inclusion in each outcomes analysis. In this case, classical model fitting was performed where all covariates 
were included in the full model and were  removed one at a time, and the model refit if covariates were not 
significant and did not improve model fit, until the most parsimonious statistically significant model was found. 
Statistical significance was set at α<0.05 level of acceptable Type I error. 
Analysis was completed in SPSS and SAS. 
Assumptions 
Assumptions were as follows:   Medicare claims data can be effectively matched for beneficiaries for 
inpatient and outpatient services, the presence of the GT modifier to express the use of telemedicine allows 
appropriate grouping of visit types and costs associated with those visit types, and the correct assignment of 






The study was limited by   the potential impact on data validity with inaccurate reporting of modifier GT 
or diagnosis code on claims. This study focused on the chronic disease categories with the highest frequency of 
telemedicine visits in the sample data. More evidence-based research on this and other chronic disease 
management is needed in the Medicare population to further identify increased access, improved outcomes, and 
any cost savings by utilizing telemedicine as a modality of treatment. Pharmacy costs were not reviewed in this 
study due to the skewness of data by the associated high costs. 
Protection of Human Subjects 
Studies using these data have been labelled as non-human research by the MUSC Institutional Review 
Board (IRB), and thus no review and approval were needed. 
Journal Article  
Abstract 
Utilization of telemedicine as a modality of treatment for chronic and acute care conditions shows promise in 
increasing access, decreasing costs, and improving patient satisfaction in the American healthcare industry.  
While telemedicine is not a new idea, only in recent years has there been the culmination of innovation, 
legislation, and advancement in practice to forge new virtual paths to high-quality treatment of patients through 
telemedicine utilization. The study design is a retrospective quasi-experimental cohort analysis of a secondary 
patient claims data from 2012 to 2014. Using data from the Medicare Limited Data Set 5% Medicare sample, 
we compare healthcare costs for two groups of Medicare beneficiaries with chronic disease, those who utilized 
a telemedicine service and those with a traditional face-to-face visit. Propensity score (PS) matching was used 
to balance the groups on baseline age, race, sex, dual eligibility for Medicare and Medicaid, and comorbid 
disease. Analysis of the cost outcome utilized a gamma distributed models with log link functions controlling 
for age, Charlson Score, and Hypertension.   After examining a six-month post visit period, our results indicated 




person visit. Telehealth is a promising approach to increase access to care and is associated with decreased costs 
for Medicare beneficiaries with chronic disease. 
Background and Need 
Healthcare costs in the United States are significantly higher than costs in other developed countries, yet 
the US struggles to improve outcomes and access for patients with chronic disease which have direct impact on 
costs (Access to Health Services; Healthy People 2020, n.d.). Lack of access to quality healthcare is far 
reaching and has major implications for chronic disease management. For example, compared to the national 
average, the Southern United States has a higher prevalence of Type 2 Diabetes Mellitus (DM2). Rural area 
designation increased the incidence of DM2. Percentages of patients diagnosed with DM2 in rural areas in the 
South who had forgone medical care decreased from 13% to 17% between 2011 and 2015 (Towne, Bolin, 
Ferdina, Nicklett, Smith, & Ory, year). Rural patients not only may have a higher disease burden, but also 
experience inequities in the supply of specialty providers. For example, of the 45.6 million rural residents, 
10.4% had access to a pulmonologist within 5 miles, 34.5% within 10 miles, 54.5% within 15 miles, and 95.2% 
within 50 miles (Croft et al., 2016). There is also a shortage of primary care physicians (PCP) in many rural 
counties especially compared to more urban areas of the country. For example, Wyoming had 90 PCP per 
100,000 residents compared to the 2013 national average of 121 physicians per 100,000  (Stingley & Schultz, 
2014). 
 Telemedicine technologies show promise in increasing access to care, improving outcomes, and 
decreasing costs for chronic disease management but more evidence is needed. More extensive, large sample 
research is needed to determine the impact of telehealth as a modality of treatment on costs and outcomes of 
care.  Telehealth has the potential to alleviate the barriers to care caused by the geographic misallocation of 
qualified healthcare providers. Telehealth services connect patients in rural or remote locations with distant 
providers via technology. A simple definition of telehealth is the utilization of telecommunications to facilitate 
health care delivery (Latoya Thomas & Gary Capistrant, 2017). In a traditional telehealth interaction, the distant 




patient by the utilization of telecommunication technologies. An originating site or spoke is the location of the 
patient at the time a service is being provided (Medicaid.gov n.d.). Table 4 identifies a variety of ways 
telecommunications are used to provide medical services via telehealth. 
One example of the positive impact of telemedicine is through the Helmsley Charitable Trust (HCT). 
The Rural Health Program, initiated by the HCT, has approved $22 million in funding for telehealth 
eEmergency Services for 85 counties in the Midwestern U.S. The HCT wanted to focus on providing funding 
for areas where immediate and sizable healthcare needs were present and where there was an absence of 
philanthropic funding. The HCT focused on connecting rural hospitals in these areas with service/hub hospitals 
outside of the frontier areas. Services provided through this eEmergency initiative increased access to quality 
care, faster transfers to higher level care facilities when needed, and decreased the number of unnecessary 
transfers (Stingley & Schultz, 2014).  
However, more research is needed to understand the costs of telemedicine for patients with chronic 
disease. A few studies that have examined costs show promising cost savings through miles saved, reduced 
patient transfers, and fewer emergency room visits (citations). In January, 2015, a study by the Telemedicine 
Services of the Veterans Health Administration completed a retrospective review of a group of veteran patients 
utilizing care coordination home telemedicine (CCHT) for chronic disease management (CDM) compared to a 
matched control group (MCG) of similar patients from 2009 to 2012. After 12 months of study, CCHT patients 
had lower healthcare costs than the MCG matched group. CCHT patients had a slight decrease of 4% in costs 
while MCG patient costs increased by 48% (p<.001). It was noted pharmacy costs rose for CCHT patients by 
22% compared to a smaller rise of 15% for MCG patients. This rise was attributed to the increased compliance 
with medical treatment. Other significant findings included an increase in the mean number of inpatient 
admissions in MCG patients from .56 to .72 days compared to a decrease in CCHT patients from .76 to .49 
days. Emergency visits decreased from .65 to .63 in MCG patients, there was a marked decrease from .84 to .58 




 According to the 2015 SCTA Annual Report, Tele Stroke services increased the administration of tissue 
plasminogen activator (tPA) by 55% from 2013 to 2014 which resulted in a potential cost savings of 
$642,244.00. tPA is a blood thinner used in early treatment of strokes and blood clots (South Carolina 
Telehealth Alliance, n.d.).  
Research Questions 
This study will address two primary research questions. 1) What are the demographic characteristics of 
chronic disease Medicare beneficiaries who utilize telemedicine services? 2) Is there a relationship between the 
use of telemedicine services and any of the following healthcare outcomes: healthcare costs, outpatient costs, 
inpatient costs, or the number of inpatient admissions for Medicare beneficiaries with chronic disease?  
Research Design 
This study design is a retrospective quasi-experimental cohort analysis of a secondary patient claims 
data from 2012 to 2014. While the use of telemedicine in the United States is on the rise, limited research has 
been performed to prove that the cost of the programs is worth the value received by patients, providers, 
insurers, and the overall healthcare system. In particular, few national studies have examined telemedicine 
outcomes with emphasis on chronic disease patients. For these reasons, this study aims to examine the 
demographic characteristics of current users of telemedicine services who are chronic disease sufferers. We will 
also compare primary cost and inpatient utilization outcomes between a propensity score weighted group of 
chronic disease patients who have indication of use of telemedicine services with those that do not. 
Data Set Description 
Medicare Limited Data Set (LDS) files were the data source for the control and study group claims 
information. The LDS file is a sample of claims data containing identifiable health information. The data set 
does not contain identifiers protected by the Health Insurance Accountability and Portability Act (HIPAA) 
(Medicare et al., 2018). Data for this study was provided by the Medical University of South Carolina (MUSC) 
and included claims data from a 5% Sample of the Limited Data Set (LDS) from October 1, 2012 through 





The study includes the Limited Data Set of MEDPAR’s 5% sample for Medicare patients who were seen 
between October 1, 2012 and September 30, 2014. Data was reviewed for beneficiaries with chronic diseases, 
as defined by the Elixhauser Comorbidity Index (ECI) and Charlson Comorbity Index (CCI) reported on claims 
data with and without modifier GT signifying the presence or absence of telemedicine. 
Data Analysis 
  We examined the LDS Medicare 5% sample from October 1, 2012 through September 30, 2014 for 
reporting of chronic disease. Chronic diseases were defined by examining the ECI for the most prevalent 
chronic diseases in adults. A list of diagnoses included in the ECI can be found in Table 5.  The ECI is a 
medically accepted list of comorbidities that can predict an increase in the utilization of healthcare resources of 
hospital inpatient services.  
We define utilization of a telemedicine visit as a report of the GT modifier on claims data. The index 
date for the study group was defined as the first appearance of modifier GT in claims data. For the control 
group, a similar diagnostic event was selected. Propensity score (PS) weighting was used to match the groups 
on baseline hospital admission, Charlson Score, age, race, sex, dual eligibility for Medicare and Medicaid, the 
presence of depression, DM, and/or Opioid use disorder, CCI and state of coverage. The use of propensity score 
weighting allows weights to be applied to balance baseline characteristics of the comparison groups to control 
for selection bias. Both the study and control group were followed for 6 months from their index date.  
After codifying the diseases listed on the ECI, Medicare 5% LDS was queried and yielded four 
prevalent categories of chronic disease for inclusion on the study group; CHF, COPD, HTN, and PVD (Table 6). 
The final sample included more than 2,000 individuals that could be followed with at least one of the identified 
chronic diseases and at least one modifier code GT within the same time period. In addition, we identified 
subgroups of comorbid patients who also have depression, DM, and/or Opioid use disorder. 
Propensity Score matching was performed using a greedy-matching algorithm and was matched in a 1 




of the propensity score model. Covariates in the PS model that have a less than 0.25 standardized difference are 
considered well-matched. The PSs were computed using a multiple logistic regression with comparison group 
(Telemedicine vs. No Telemedicine) as the dependent variable. PS and outcome models account for 
demographics and clinical characteristics that may influence comparison group selection or may be related to 
outcome risk. All of these designated covariates were included in the PS model and tested for inclusion in the 
outcome analyses models to account for a doubly robust analysis methodology for quasi-experimental studies 
(Harder et al., 2010; Little & Rubin, 2000; Paul R Rosenbaum & Donald B Rubin, 1983). To assess Aim 1, 
describing the population of telemedicine users, chi-square (for categorical variables) and t-tests (for normally-
distributed continuous variables) was used to describe the differences in demographic characteristics across 
those patient groups who utilized telemedicine services and those who did not.  
After the propensity score matching, a series of multivariable models were constructed to make formal 
statistical comparisons testing the hypothesized differences between the telemedicine and no telemedicine 
groups.  Generalized linear regression models were used to make these comparisons. Cost outcomes utilized 
Gamma distributed models with log link functions due to the skewed nature of costs. Due to the count nature of 
the number of inpatient visits, a Negative Binomial distributed model with a log link function will be used to 
test differences in this outcome. The same covariates used in the PS model will be tested for inclusion in each 
outcomes analysis. In this case classical model fitting will be performed where all covariates are included in the 
full model and will be removed one at a time and the model refit if they are not significant and do not improve 
model fit until the most parsimonious statistically significant model is found. Statistical significance will be set 
at the<0.05 level of acceptable Type I error. Analysis was completed in SPSS and SAS.  The study was 
determined non-human research by the MUSC Institutional Review Board (IRB).  
Results 
 The total number of observations in this study was 4798, including 2399 patient encounters in the 
control (face-to-face) group and the telemedicine group. Table 1 shows the weighted demographic 




patient race across the two groups (p<0.0001). In addition, the telemedicine group had a higher percentage of 
dual eligible patients (p<0.0001). In the control group, 35% of the beneficiaries were Dual Eligible (DE) for 
Medicare and Medicaid, while 65% of the telemedicine group were DE.  The control group had a higher 
percentage of patients with hypertension (p<0.0001), diabetes (p<0.0001) and opioid abuse (p=0.0184). The 
mean age in the control group was 60.37 years compared to the mean in the telemedicine group at 58.26 
(p<0001).  
 When examining the unadjusted outcomes, we found the telehealth group had a significantly higher use 
of inpatient hospital days compared to the control group, 4.7 vs 3.85 days respectively (p=0.0082). The 
unadjusted total costs were $1503 lower in the telemedicine group ($11,818 vs $13,321). However, this 
difference was not statistically significant (p=0.4127). Unadjusted outpatient costs were found to have a 
significant mean difference of $259.50 (p=0.0118) with higher costs   in the control group. Inpatient unadjusted 
costs were found to have a significant mean difference of $1,181.50 (p=0.0202) with lower costs  in the study 
group.  
 Before implementing the PS matching (Figure 1), hypertension, age, Charleson Score, and baseline 
hospitalization were out of balance between the two groups. Results of the PS matching show no differences 
between treatment and control groups for all variables, except for hypertension. The mean difference for 












Figure 1: Standardized Variable Differences 
 
We compared the total 6-month post index visit cost for the propensity-score matched telehealth group to the 
control population using a multivariable regression analysis with a gamma-distributed log link model to account 
for the skewness of cost data. We controlled for HTN in this model, because this variable was not completely 
accounted for in our matching process. We also controlled for age and Charlson Score to ensure that any small 
imbalance in these variables that are closely associated with cost did not bias our estimate.  The adjusted mean 
total cost was $10,639 (CI 10,040-11,274) for the Telehealth group, and $12,467 (CI 11,765-13211) for the 
comparison group (p=.0002). Thus, we observed a cost saving of $1,828 for the Telehealth group. 
Discussion 
Our study found a significant 6 months savings of $1828 associated with the chronic disease 
beneficiaries utilizing a telemedicine visit. To our knowledge, this is the first study to compare Medicare 
beneficiaries’ healthcare costs when using telemedicine. Telehealth utilization remains a small portion of 
healthcare delivery. If the savings could be extrapolated across a wider population of chronic disease patients, 
there is a potential for additional improvements to the costs of healthcare. More research is needed to 




 We also observed that the Medicare beneficiaries who utilized telemedicine were younger and more 
likely to be Dual Eligible. This indicates that the young disabled Medicare Beneficiaries are more frequently 
trying telehealth services. This finding is similar to telehealth studies which indicate that younger patients are 
more likely to adopt technology (EHRIntelligence, 2014). Therefore, telemedicine may be a promising 
approach to managing chronic diseases in young or disabled patients. 
This study has several limitations. First, there is a potential impact on data validity with inaccurate 
reporting of modifier GT or diagnosis code(s) on claims. Next, this study focused on the chronic disease 
categories with the highest frequency of telemedicine visits in the sample data but did not include remote 
patient monitoring, which is a common telehealth service for chronic disease management. Finally, due to 
limitations in the dataset, we were unable to assess if the telehealth visit was related to chronic disease 
management or other healthcare purposes. This study did not consider beneficiaries’ home zip code or treatment 
zip code. More research is needed to determine locations where telemedicine is used and to compare costs and 
utilization for locations where telemedicine is not being used. More research is needed to explore the costs 
associated with utilizing telehealth for chronic disease management. 
Conclusion 
 Telehealth is a promising approach to increasing access to care and is associated with decreased costs for 
Medicare beneficiaries with chronic disease. All actors in the medical community including clinicians, 
legislators, payers, businesses, and patients, should continue expanding telemedicine utilization, offerings, 

























 Telemedicine Group                               
(n=2399) 
p value 
Age mean (std) 59.32(15.39) 60.37(14.55) 58.26(16.12) <.0001 
Gender, No. (%)  
   
.05413 
Female 2689(56.04) 1355 (56.48) 1334 (55.61)  
Male 2109(43.96) 1044 (43.52) 1065 (44.39) 0.5413 
Race, No. (%) 
   
<.0001 
Unknown 26(.54) 9 (0.03) 17(0.7)  
White 3864(80.53) 1939(80.83) 1925(80.24)  
Black 633(13.19) 325(13.54) 308(12.84)  
Other 29(.60) 15(0.63) 14(0.58)  
Asian  
43(.90) 33(1.38) 10(0.42) 
 
Hispanic 130(2.71) 57(2.38) 73(3.04)  
North American 
Native 73(1.52) 21(0.88) 52(2.17) 
 
Dual Eligible, No. 
(%)    
 
Dual Eligible  4798  1622(67.61) 1479(61.65)               <.0001 
Chronic Disease, No. 
(%)    
 
COPD 726(15.13) 374(15.59) 352(14.67) 0.3755 
CHF  319(6.65) 144(6.0) 175(7.29) 0.0724 
HTN 3189(66.47) 1785(74.41) 1404(58.52) <.0001 
PVD 312(6.50) 166(6.92) 146(6.09) 0.2415 
Comorbid Conditions 
No. (%)    
 
DM  1407(29.32) 794(33.1) 613(25.55) <.0001 
Depression 1003(20.90) 519(21.63) 484(20.18) 0.2140 
Opioid abuse 772(16.09) 416(17.34) 356(14.84) 0.0184 
Charlson Comorbity 





Table 2: Unadjusted Non-Cost Outcomes 
 
 
Table 3: Unadjusted Cost Outcomes 
 
 
Reference Tables  
 
TABLE 4 Center for Connected Health Policy (CCHP) Definitions 
Live Video (real-time) 
Live, two-way interaction between a patient or representative 
(patient, caregiver, or provider) and a healthcare provider using 
audiovisual telecommunications technology.  This modality may 
serve as a substitute for an in-person encounter. 
Store-and-forward 
(asynchronous) 
Transmission of recorded health history for example, records, 
reports and images, through secure electronic exchange via 
communications system to a practitioner who uses the 
information to make medical decisions outside of a real-time 
interaction. 
Remote patient monitoring 
Personal health and medical information collection via 
electronic communication technologies that is transmitted to a 
provider in a different location used for medical decision 
making. This type of service allows a provider to continue to 
track healthcare data for a patient via telecommunication 
technologies 
Mobile health (mHealth)  
Private and public healthcare practice and knowledge used to 
support better self-management of care. These 
telecommunication technologies are supported by mobile 









    
Admissions  0.58 (1.21) 
 
0.59 (1.14) 0.6119 
Days 3.85 (10.78) 
 
4.7 (11.40) 0.0082 
Cost Type Control Mean (SD) Study Mean (SD) P-
value 
Overall Costs mean (std) $13,321 (27,501) $11,818 (1,791) 0.0298 
Outpatient Costs mean (std) $2,467 (3,835) $2,207 (3,282) 0.0118 







Table 5: Comorbidity Indices  
ELIXHAUSER 
Congestive Heart Failure 
Cardia Arrhythmia 
Valvular Disease 
Pulmonary Circulation Disorders 





Other Neurological Disorders 






Peptic Ulcer Disease Excluding Bleeding 
AIDS/HIV 
 Lymphoma 
 Metastatic Cancer 
 Solid Tumors without Metastasis 
 Rheumatoid Arthritis/Collagen Vascular Diseases 
 Coagulopathy 
 Obesity 
 Weight Loss 
 Fluid and Electrolyte Disorders 
 Blood Loss Anemia 
 Deficiency Anemia 
 Alcohol Abuse 







Table 6: PS Table Condition Variables 
 
*New indicator variables will be developed based on any of the ICD-9 codes listed in any of the Primary (DX1) 












V1 Congestive heart failure 391.80,392.0,398.91,402.01,402.11,402.91,404.91,4
04.93,428.0
V2 Peripheral vascular disease 443.22,443.81,443.9,440.2,440.20,440.21,440.22,44
0.23,440.24,440.29,440.3,440.30,440.31,440.32,440
.8,440.9












C1 Opioid Abuse (unspecified, 
continuious, episodic, in remission)
305.50,305.51,305.52,350.53
C2 Depression (depressive disorder 
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